RSS
Forendo Pharma
Forendo Pharma raises additional funding to accelerate development of women’s health portfolio
Clinical stage drug development company, Forendo Pharma, has raised an additional €4 million of funding from Vesalius Biocapital III Partners, which will be used with other raised funds to accelerate the development of its women’s health portfolio. Read more
Forendo Pharma receives €3 million loan to support development of endometriosis treatment
Forendo Pharma — portfolio company of Karolinska Development — has been granted a €3 million loan from Business Finland to support the development of a novel drug for the treatment of endometriosis. Read more
